Price $48.27 |
Market Cap
12.75B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
5.95
|
P/S
3.91
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
19.8
|
Op. Cash Flow
704.5K
|
FCF
2.4
|
|
Op. Margin
1.50%
|
Net Margin
-0.30%
|
ROE
-0.40%
|
ROI
-5.60%
|
|
ROA
-0.20%
|
EPS Growth
89.50%
|
Current Ratio
1.2
|
Debt/Equity
112.20%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Champions Oncology Inc (CSBR) | $7.59 | - | - | 90.7M | Strong Buy |
| MTBC Inc (MTBC) | $4.62 | - | - | 58.3M | Strong Buy |
| Lannett Company, Inc. (LCI) | $5.98 | - | - | 232M | Strong Buy |
| Invo Bioscience Inc (IVOB) | $0.31 | - | - | 62.2M | Strong Buy |
| Assertio Therapeutics Inc (ASRT) | $3.00 | - | - | 221.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
